Irving Investors

Venture Capital

Irving Investors is a growth-oriented, sector-agnostic crossover investment firm founded in 2009 by Jeremy Abelson. The firm runs a single-name strategy combining a predominantly long-only public equities book with an active late-stage venture portfolio, frequently taking board seats. Headquartered in Denver, Colorado with an additional office in New York, Irving has backed technology and healthcare companies including unicorns Snyk and Rebel Foods, and has seen multiple IPO and acquisition exits, most recently Cybereason (acquired by LevelBlue, October 2025).

New York, United States · 6+ investments

Growth
Early Stage
Late Stage
Healthcare
Headquarters
New York, United States
Founded
2009
Total Investments
6
Last Investment
Nov 2021
Geographic Focus
United States

Investment Thesis

We invest in technology.

Irving Investors is a Venture Capital firm based in New York, United States. It has made 6 investments in Healthcare.

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Irving Investors on Indexed.vc
<a href="https://indexed.vc/investors/irving-investors"><img src="https://indexed.vc/api/badge/investor/irving-investors" alt="Irving Investors on Indexed.vc" width="260" height="76" /></a>